ALS untangled no. 20: The Deanna protocol

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 4, 2013, Pages 319-323

  Fournier, Christina ^a   Bedlack, Richard ^a   Hardiman, Orla ^a   Heiman Patterson, Terry ^a   Gutmann, Laurie ^a   Bromberg, Mark ^a   Ostrow, Lyle ^a   Carter, Gregory ^a   Kabashi, Edor ^a   Bertorini, Tulio ^a   Mozaffar, Tahseen ^a   Andersen, Peter ^a   Dietz, Jeff ^a   Gamez, Josep ^a   Dimachkie, Mazen ^a   Wang, Yunxia ^a   Wicks, Paul ^a   Heywood, James ^a   Novella, Steven ^a   Rowland, L P ^a   Pioro, Erik ^a   Kinsley, Lisa ^a   Mitchell, Kathy ^a   Glass, Jonathan ^a   Sathornsumetee, Sith ^a   Kwiecinski, Hubert ^a   Baker, Jon ^a   Atassi, Nazem ^a   Forshew, Dallas ^a   Ravits, John ^a   Conwit, Robin ^a   Jackson, Carlayne ^a   Sherman, Alex ^a   Dalton, Kate ^a   Tindall, Katherine ^a   Gonzalez, Ginna ^a   Robertson, Janice ^a   Phillips, Larry ^a   Benatar, Michael ^a   Sorenson, Eric ^a   Shoesmith, Christen ^a   Nash, Steven ^a   Maragakis, Nicholas ^a   Moore, Dan ^a   Caress, James ^a   Boylan, Kevin ^a   Armon, Carmel ^a   Grosso, Megan ^a   Gerecke, Bonnie ^a   Wymer, Jim ^a   Oskarsson, Bjorn ^a   Bowser, Robert ^a   Drory, Vivian ^a   Shefner, Jeremy ^a   Lechtzin, Noah ^a   Leitner, Melanie ^a   Miller, Robert ^a   Mitsumoto, Hiroshi ^a   Levine, Todd ^a   Russell, James ^a   Sharma, Khema ^a   Saperstein, David ^a   McClusky, Leo ^a   MacGowan, Daniel ^a   Licht, Jonathan ^a   Verma, Ashok ^a   Strong, Michael ^a   Lomen Hoerth, Catherine ^a   Tandan, Rup ^a   Rivner, Michael ^a   Kolb, Steve ^a   Polak, Meraida ^a   Rudnicki, Stacy ^a   Kittrell, Pamela ^a   Quereshi, Muddasir ^a   Sachs, George ^a   Pattee, Gary ^a   Weiss, Michael ^a   Kissel, John ^a   Goldstein, Jonathan ^a   Rothstein, Jeffrey ^a   Pastula, Dan ^a   Levitsky, Gleb ^a   Ogino, Mieko ^a   Rosenfeld, Jeffrey ^a   Carmi, Efrat ^a   Oster, Craig ^a   Barkhaus, Paul ^a   Valor, Eric ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 5 HYDROXYTRYPTOPHAN; ARGININE ALPHA KETOGLUTARATE; COLECALCIFEROL; CREATINE; GINKGO BILOBA EXTRACT; GLUTATHIONE; GLYCINE; IDEBENONE; MAGNESIUM; NICOTINAMIDE ADENINE DINUCLEOTIDE; PHOSPHATIDYLCHOLINE; PROPOLIS; RILUZOLE; TAURINE; THEANINE; UNCLASSIFIED DRUG; VITAMIN D;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BLOOD FLOW; CLINICAL PROTOCOL; DEANNA PROTOCOL; DIET SUPPLEMENTATION; DISEASE COURSE; ENERGY YIELD; EXCITOTOXICITY; EXERCISE; GINKGO BILOBA; HUMAN; KETOGENESIS; MOTOR CORTEX; NEUROTRANSMISSION; NUTRITIONAL SUPPORT; ORTHOPEDIC SURGEON; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DIETARY SUPPLEMENTS; HUMANS; NUTRITION THERAPY; PLANT OILS;

EID: 84877868474     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.788405     Document Type: Review

References (34)

1. http://www.cbn.com/cbnnews/healthscience/2012/November/ Deanna-Protocol-a-Breakthrough-for-Lou-Gehrigs/.
2. Berg J M, T ymoczko J L, S tryer L. In: F reeman WH, editor. Biochemistry : 5th edn. New York: 2002
3. Moncada S, H iggs A. T he L-arginine-nitric oxide pathway. N Engl J Med. 1993; 329 : 2002-12
4. Liu Y, L ange R, L angansky J, H amma T, Y ang B, S teinacker JM. Improved training tolerance by supplementation with alpha-keto acids in untrained young adults: A randomized, double-blind, placebo-controlled trial. J Int Soc Sports Nutr. 2012; 9 : 37
5. Hammarqvist F, W ernerman J, v on der Decken A, Vinnars E. Alpha-ketoglutarate preserves protein synthesis and free glutamine in skeletal muscle after surgery. Surgery. 1991; 109 : 28-36
6. Joyner M J. G lutamine and arginine: Immunonutrients and metabolic modulators? Exerc Sport Sci Rev. 2005; 33 : 105-6 (Pubitemid 40994561)
7. Carbone C, P ignatello R, M usumeci T, P uglisi G. C hemical and technological delivery systems for idebenone: A review of literature production. Expert Opin Drug Deliv. 2012; 9 : 1377-92
8. Foerster B R, C allaghan B C, P etrou M, E dden R AE, Chenevert TL, Feldman EL. Decreased motor cortex gamma-aminobutyric acid in amyotrophic lateral sclerosis. Neurology. 2012; 78 : 1596-600
9. D'Alessandro G, C alcagno E, T artari S, R izzardini M, Invernizzi R, Cantoni L. Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism. Neurobiol Dis. 2011; 43 : 346-55
10. Martin LJ. M itochondrial pathobiology in ALS. J Bioenerg Biomembr. 2011; 43 : 569-79
11. Swerdlow R H, P arks J, C assarino D, T rimmer P, M iller S, Maguire D.et al. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp Neurol. 1998; 153 : 135-42 (Pubitemid 28452305)
12. Tieu K, P erier C, C aspersen C, T eismann P, W u DC, Yan S.D.et al. D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson's disease. J Clin Invest. 2003; 112 : 892-901 (Pubitemid 38063747)
13. Redler RL, D okholyan NV. T he complex molecular biology of amyotrophic lateral sclerosis (ALS). Prog Mol Biol Transl Sci. 2012; 107 : 215-62
14. Cleveland D W, R othstein J. F rom Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat Rev Neurosci. 2001; 2 : 806-19 (Pubitemid 33674062)
15. Lacomblez L, B ensimon G, L eigh PN, G uillet P, P owe L, Durrleman S, et al. A confi rmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology. 1996; 47(Suppl 4) : S242-50 (Pubitemid 26422577)
16. Petri S, K orner S, K iaei M. N rf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS. Neurol Res Int. 2012 ; 2012 : 878030
17. Borg J, L ondon J. Copper/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro. J Neurosci Res. 2002; 70 : 180-9
18. Personal communication with Dominic D'Agostino, Department of Molecular Pharmacology and Physiology at the University of Southern Florida
19. Zhao Z, L ange D, V oustianiouk A, M acGrogan D, H o L, Suh J, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006; 7 : 29
20. Matthews R T, Y ang L, B rowne S, B ajk M, B eal M F. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci U S A. 1998; 95 : 8892-7
21. Klivenyi P, F errante RJ, M atthews RT, B ogdanov MB, Klein AM, Andreassen O.A.et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Medicine. 1999; 5 : 347-50 (Pubitemid 29124375)
22. Kaufmann P, T hompson J L, L evy G, B uschsbaum R, Shefner J, Krivickas L.et al. Phase II trial of CoQ10 for ALS fi nds insuffi cient evidence to justify phase III. Ann Neurol. 2009; 66 : 235-44
23. Pastula DM, M oore D H, B edlack RS. C reatine for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews. 2012; 12 : 1-27
24. Ghoddoussi F, G alloway MP, J ambekar A, B ame M, Needleman R, Brusilow WS. Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. J Neurol Sci. 2010; 290 : 41-7
25. Ghadge G D, S lusher B, B odner A, D al Canto M, Wozniak K, Thomas A.et al. Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models. Proc Natl Acad Sci U S A. 2003; 100 : 9554-9 (Pubitemid 37033966)
26. Wang R, Z hang D. M emantine prolongs survival in an amyotrophic lateral sclerosis mouse model. Eur J Neurosci. 2005; 22 : 2376-80 (Pubitemid 41653551)
27. Rothstein J D, S arjubhai P, M elissa R, H aenggeli C, Huang Y, Bergles D, et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005; 433 : 73-7 (Pubitemid 40101145)
28. Verstraete E, V eldink J, H uisman M, D raak T, U ijtendaal E, van der Kooi A.et al. Lithium lacks effect on survival in amyotrophic lateral sclerosis: A phase IIb randomized sequential trial. J Neurol Neurosurg Psychiatry. 2012; 83 : 557-64
29. http://www.alsworldwide.org/ceftriaxone.html
30. de Carvalho M, P into S, C osta J, E vangelista T, O hana B, Pinto A. A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010; 11 : 456-60
31. Ryberg H, A skmark H, P ersson L. A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine:Effects on CSF glutamate, aspartate, branchedchain amino acid levels and clinical parameters. Acta Neurol Scand. 2003; 108 : 1-8 (Pubitemid 36791985)
32. Miller R G, M oore D H, G elinas D, D ronsky V, M endoza M, Barohn R.et al. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology. 2001; 56 : 843-8 (Pubitemid 32293584)
33. Krochmal R, H ardy M, B owerman S, L u Q, W ang H, Elashoff R, Heber D. Phytochemical assays of commercial botanical dietary supplements, eCAM. 2004 ; 1 : 305-13
34. http://www.iom.edu/Activities/Nutrition/SummaryDRIs/? / media/Files/Activity%20Files/Nutrition/DRIs/5-Summary% 20Table%20Tables%201-4. pdf